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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: To analyze the preoperative conditions and postoperative outcomes of
phacoemulsification and intraocular lens implantation in Taiwanese patients with uveitis.
Methods: This retrospective, consecutive case series study included 121 eyes of 84 patients
with uveitis who underwent phacoemulsification and intraocular lens implantation from July
1996 to May 2006. The demographic data, postoperative outcomes, complications, and risk
factors with regard to visual prognosis were analyzed. Visual acuity was converted from the
Snellen equivalent to logMAR values.
Results: This study included 51 men and 70 women with a mean  SD age of 44.6  18.4 years.
The three most common diseases were idiopathic uveitis, Behcet’s disease, and Vogt
eKoyanagieHarada disease. The best-corrected visual acuity improved from 1.52  0.83 log-
MAR units preoperatively to 0.37  0.59 logMAR units postoperative (p < 0.001). The most
frequent postoperative complications were posterior capsular opacity (24 eyes) and cystoid
macular edema (10 eyes). Anterior uveitis related to HLA-B27 had the best visual prognosis,
whereas Behcet’s disease had the poorest visual outcome (pZ 0.029). Logistic regression anal-
ysis indicated that disease etiology (p Z 0.011) and preoperative visual acuity (p Z 0.020)
were related to the postoperative visual prognosis.
Conclusion: Cataract extraction can improve visual function for most patients with uveitis.
Postoperative complications were not uncommon and Behcet’s disease had the poorest post-
operative visual prognosis.
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378 C.-P. Lin et al.Introduction after surgery, posterior synechiae, pupillary capture of IOL,Cataracts are common in patients with uveitis due to
frequent intraocular inflammation and the long-term use of
steroids.1,2 Cataracts may result in severe visual dysfunc-
tion, prompting the consideration of cataract surgery.
Conventional extracapsular cataract extraction with pos-
terior capsular intraocular lens (IOL) implantation in pa-
tients with uveitis has been associated with various
complications.3 Intraocular lens selection, the preoperative
and postoperative management of inflammation, and
consequent complications such as band keratopathy, miotic
pupil, iris atrophy, pupillary membrane formation, and IOL
capture are all challenging problems.4 However, the out-
comes of cataract surgery in patients with uveitis have
become more favorable with modern techniques of
phacoemulsification and new designs of IOL.5e7
Most studies investigating cataracts in patients with
uveitis have been reported from western countries, which
have different patterns of uveitis from countries in Asia. A
literature review showed only one related East Asian study,
reported from Japan.8 Because the rate of cataract for-
mation varies for different types of uveitis and the pre-
dominant types of uveitis are not usually the same among
different races,9 data from various parts of the world may
show large differences. The purpose of this study was to
analyze the preoperative conditions and postoperative
outcomes of cataracts associated with uveitis in Taiwan and
to explore the possible risk factors for a poor prognosis.
Methods
From July 1996 to May 2006, the medical records of
consecutive patients with uveitis who underwent cataract
surgery by a single surgeon (C.-P. Lin) in the National
Taiwan University Hospital, a tertiary care referral center,
were reviewed. All the patients had confirmed uveitis, were
undergoing treatment and follow-up at the same hospital,
and underwent phacoemulsification because a cataract
disabled their vision. All patients were followed up post-
operatively for more than 6 months. Patients with a history
of eye trauma, those with diabetes mellitus, and patients
with cataracts related to previous ocular surgery were
excluded. Each patient underwent small incision phaco-
emulsification cataract extraction and IOL implantation
under either topical or local anesthesia. A complete work
up of the patient’s medical history relating to uveitis and
ophthalmic examinations were routinely performed in all
patients before cataract surgery. The surgery was per-
formed only after intraocular inflammation had been
brought to a quiescent stage for at least 3 months based on
physical examinations, unless complications or impending
complications prompted an early operation. Patient pro-
files, including sex, age at onset, uveitis etiology, age,
preoperative findings, quiescent periods of intraocular
inflammation before surgery, length of follow-up, and the
presence of surgical complications, postoperative compli-
cations, and associated management were recorded.
The following changes were regarded as postoperative
complications: a relapse of inflammation within 6 monthsan increase in intraocular pressure (over 25 mmHg) that
required treatment within 6 months after surgery, posterior
capsule opacification (PCO) that required neodymium:YAG
laser capsulotomy, and postoperative cystoid macular
edema (CME) confirmed by optical coherence tomography.
The best-corrected visual acuity (BCVA) was recorded at
the last preoperative visit and at every postoperative
follow-up visit. The Institutional Review Board Committee
of National Taiwan University Hospital approved the study.
Preoperative drug treatments
All patients maintained their drug doses preoperatively and
added topical 1% prednisolone acetate four times each day
for 1 week and 40 mg prednisolone (5 mg/tablet) by mouth
each day for 3 days. An steroid given by mouth was pre-
scribed until the day of surgery.
Surgical techniques
Each patient underwent clear corneal incision with a
2.5 mm diamond knife. Synechiolysis was performed using
an iris hook or iris retractors and small sphincterotomies
were performed if judged necessary. In patients with white
cataract, continuous curvilinear capsulorhexis assisted by
indocyanine green (0.5%) was performed. After completing
continuous curvilinear capsulorhexis, the lens nucleus was
removed by phacoemulsification, with phaco chop as the
main technique. The cortical material was subsequently
removed by the irrigation/aspiration method. With the aid
of an ophthalmic viscosurgical device, an IOL was implan-
ted in the capsular bag (except in 3 patients with juvenile
uveitis who remained aphakic, to prevent IOL capture) and
the incision was sealed by corneal hydration (one-stitch
corneal suture with 10-0 nylon, as required). A subcon-
junctival injection of 0.5 mL dexamethasone (1 mg/mL) and
0.5 mL gentamicin (2 mg/mL) was administered at the end
of surgery.
Postoperative care
All patients with Behcet’s disease (27 patients) receiving
systemic immunosuppressants before cataract surgery
maintained their original doses during the preoperative and
postoperative course. Patients were followed up on the 1st
postoperative day and 1 week, 1 month, and every 3
months thereafter. The postoperative drugs included
topical 0.1% dexamethasone applied once every 2 hours for
2e3 weeks; however, this drug was sometimes tapered in
patients who had a history of uveitis, but who had main-
tained a quiescent status for a long time. Prednisolone
(5 mg/tablet) by mouth was prescribed at 30 mg/day for
the first 3 days, followed by 20 mg/day for 2 days, and then
10 mg/day for 2 days. If severe inflammation occurred, a
higher dose of topical steroid and steroid by mouth was
given (a 2 mg betamethasone subconjunctival injection or
40 mg triamcinolone subtenon injection), as required. For
intractable cases, systemic nonsteroidal anti-inflammatory
drugs (e.g. indomethacin or diclofenac), immune
Cataract surgery outcomes in patients with uveitis 379modulators (e.g. sulfasalazine), immunosuppressants (e.g.
cyclosporin and azathioprine), or chemotherapy (e.g.
methotrexate) were used. The IOL was removed if all the
conservative management techniques were unsuccessful.
Statistical analysis
To examine the differences in BCVA before and after sur-
gery, the Snellen chart visual acuity was converted into
logMAR units. A visual acuity (VA) of finger counting was
assigned a logMAR of 2.5 and a poorer visual acuity was
assigned a logMAR of 3.0. Statistical analyses of noncon-
tinuous variables were performed with the chi-square test
or Fisher’s exact test. For comparing the frequency of
uveitis relapse before and after surgery, only those patients
who had been free of inflammation for an interval of 3
months postoperatively were included. Continuous vari-
ables are presented as the mean  standard deviation (SD)
and the KruskaleWallis test was performed to make com-
parisons between groups. The paired t test was used to
compare the differences between preoperative and post-
operative VA. Logistic regression analysis was used to
determine the risk factors of poor postoperative VA (less
than 20/40) and this analysis included age, preoperative
VA, etiologies of uveitis, and cataract types. All statistical
analyses were performed by using STATA 8.2 software
(StataCorp LP, College Station, TX, USA). A value of
p < 0.05 was considered statistically significant.
Results
This study included 84 patients (121 eyes), 37 male patients
(51 eyes) and 47 female patients (70 eyes). The mean  SD
age at surgery was 44.6  18.4 years (range 7.5e83 years).
The clinical diagnosis was categorized into idiopathic
anterior uveitis (30 eyes), Behcet’s disease (27 eyes),
VogteKoyanagieHarada disease (VKH) (24 eyes), anterior
uveitis related to HLA-B27 (22 eyes), intermediate uveitis
(five eyes), sarcoidosis (five eyes), panuveitis (four eyes),
and juvenile uveitis (four eyes). Table 1 gives the clinical
and demographic data of the different groups.Table 1 Clinical and demographic data for patients in this stud





Idiopathic uveitis 21 (6/15) 30 (7/23) 51.4  16.5
Anterior uveitis 19 (9/10) 22 (12/10) 50.2  19.5
Intermediate
uveitis
3 (2/1) 5 (3/2) 29.8  10.7
Panuveitis 3 (1/2) 4 (1/3) 45.4  24.5
Behcet’s disease 17 (11/6) 27 (16/11) 34.7  13.7
VKH 15 (5/10) 24 (8/16) 49.0  15.9
Sarcoidosis 3 (2/1) 5 (3/2) 50.9  15.6
Juvenile uveitis 3 (1/2) 4 (1/3) 12.4  0.9
Total 84 (37/47) 121 (51/70) 44.6  18.4
Data for age, mean follow-up, and logMAR presented as mean  SD.
F Z female; M Z male; VA Z visual acuity; VKH Z VogteKoyanagieThe mean  SD durations of preoperative and post-
operative follow-upwere 3.2 2.4 years and 3.8 2.3 years,
respectively. All eyes were followed up for more than 6
months and 105 eyes were followed up formore than 2 years.
The mean  SD preoperative and postoperative 6-month
logMAR BCVAs were 1.52 0.83 and 0.37 0.59, respectively
(p < 0.001), and only 34 eyes (28.1%) did not reach 20/40.
Fig. 1 shows the individual preoperative and postoperative
changes in VA. Only one eye with light perception preopera-
tively (sarcoidosis) showed no improvement after surgery. In
the subgroups based on a diagnosis that contained 10 ormore
eyes, anterior uveitis related to HLA-B27 had the greatest
visual improvement (logMAR, 1.30  0.61), followed by
VKH (1.22  0.63) and idiopathic uveitis (1.23  0.86);
patients with Behcet’s disease had the lowest visual gain
(0.79  0.44) (pZ 0.029).
There were 28 eyes with pre-existing retinal lesions,
glaucoma, or optic neuropathy including macular scar or
atrophy (8 eyes), retinal sequelae of exudative retinal
detachment (6 eyes), epiretinal membrane (4 eyes), old
vasculitis (3 eyes), CME (3 eyes), macular hole (2 eyes),
pale disc (1 eye), and advanced glaucoma (1 eye) preop-
eratively. In these 28 eyes, the mean  SD preoperative and
postoperative logMAR VA were 1.81  0.88 and 0.79  0.85,
respectively (p < 0.001) (Fig. 1). After excluding those eyes
with pre-existing posterior pole lesions, glaucoma, or optic
neuropathy, the mean  SD visual outcomes improved to
logMAR 0.25  0.44. Compared with these 28 eyes and the
eyes without pre-existing retinal or optic nerve lesions, the
preoperative VA had no statistical significance between the
two groups (p Z 0.11). However, postoperative vision was
statistically worse in the eyes with pre-existing lesions than
in the eyes without lesions (p < 0.001).
Of the 105 eyes in the 2-year follow-up group, 28 eyes
(26.7%) had a visual deterioration of more than three lines
due to complications such as PCO (24 eyes, 8 eyes combined
with CME and 1 eye combined with glaucoma), CME (10
eyes), epiretinal membrane (1 eye, which also had CME),
glaucoma progression (2 eyes), and pupillary membrane
formation with IOL pupillary capture (1 eye).
The lens status at surgery was as follows: 91 eyes (75.2%)
had posterior subcapsular cataract, 14 eyes (11.6%) hady with uveitis.






4.6  2.6 1.36  0.84 4.2  2.4 0.22  0.35
1.0  0.8 1.58  0.74 2.2  2.1 0.29  0.24
0.8  0.3 1.26  0.77 4.6  0.6 0.08  0.10
3.8  1.7 0.73  0.20 3.2  1.5 0.14  0.25
4.1  2.4 1.50  0.89 4.2  2.2 0.08  0.82
3.4  2.3 1.37  0.58 4.1  2.7 0.17  0.23
1.9  0.7 2.80  0.27 5.1  2.2 1.08  1.30
2.3  1.1 2.75  0.50 2.2  0.5 0.03  0.59
3.2  2.4 1.52  0.83 3.8  2.3 0.37  0.59
Harada disease.
Figure 1 Distribution of pre-existing retinal lesions, glaucoma, and optical neuropathy in different diseases of uveitis in 28
patients. AAU Z acute anterior uveitis; CME Z cystoid macular edema; ERD Z exudative retinal detachment; ERM Z epiretinal
membrane; VKH Z VogteKoyanagieHarada disease.
380 C.-P. Lin et al.pure nuclear sclerosis, and 16 eyes (13.2%) were classified
as having total opacity. Among the latter 16 eyes, six eyes
received surgery while chronic inflammation persisted, four
eyes presented with an inflammation-free interval of less
than 6 months, and six eyes were free of inflammation for
more than 6 months. The mean  SD postoperative logMAR
VA was 0.20  0.41 in these eyes. Excluding the four eyes
with retinal morbidity noted perioperatively, 75% of the
eyes with total opacity had favorable visual outcomes with
an average logMAR visual improvement of 0.14  0.07 at 6
months after surgery. Severe ocular morbidity developed in
two eyes with this lens status 3 years after surgery, one
with uveitis glaucoma and one with chronic inflammation
with an intractable pupillary membrane and band kerat-
opathy, which ultimately lead to a visual deterioration to
hand motion (Table 2). Logistic regression results indicated
that the disease etiology (p Z 0.011) and preoperative VA
(p Z 0.020) were related to the postoperative visual
prognosis.
After the surgery, 86 eyes (71.1%) maintained an
inflammation-free interval of more than 6 months, whereas
14 eyes (11.6%) presented with another inflammation
episode within 6 months (mean  SD onset 1.6  1.4
months) and 21 eyes (17.3%) showed persistent chronic
inflammation. Patients with chronic inflammation without a
distinct inflammation-free interval were excluded when the
relapse frequency before and after surgery were compared,
resulting in a total of 62 eyes for the analysis. All of the
subgroups with more than 10 eyes (idiopathic anterior
uveitis, anterior uveitis related to HLA-B27, Behcet’s dis-
ease, and VKH) had a decreased relapse frequency after
cataract surgery (p < 0.05). Moreover, the postoperative
uveitis relapse frequency (per year) was significantly
decreased compared with the preoperative frequency(p < 0.001) (Table 3). Further analysis showed that 96% of
eyes had a frequency of relapse less than once per year.
Preoperative chronic inflammation (persistent uveitis
with relapse <3 months after discontinuing treatment) was
observed in 24 eyes.10 After surgery, the intractable
inflammation resolved in 15 eyes (62.5%) within 1 month.
Persisting uveitis was found in the other nine eyes (37.5%),
one of which experienced severe and intractable inflam-
mation even after IOL removal 3 months after surgery.
Ten of 77 eyes (13.0%) with a visible fundus without a
pathological change preoperatively had new onset CME
after surgery, all of which were confirmed by optical
coherence tomography (Table 4). The mean  SD onset
period was 3.6  2.5 months postoperatively, and the VA
decreased to 0.54  0.33 as a result of CME. All eyes with
CME were treated with a monthly posterior subtenon in-
jection of triamcinolone (40 mg) and the VA of these eyes
improved to 0.25  0.25 at 3 months after the injections
(p Z 0.04).
Pupillary capture of IOL was found in three eyes in which
chronic inflammation without an inflammation-free interval
had occurred between preoperative and postoperative
follow-up. Two of these eyes were implanted with a three-
piece acrylic IOL and one eye was implanted with a three-
piece polymethyl methacrylate (PMMA) IOL with a heparin-
modified surface.
Patients who were followed up for more than 2 years
postoperatively were included in the analysis of the rela-
tionship between IOL design and PCO. Of the pseudophakic
and well-documented eyes, 110 IOLs were implanted. The
acrylic three-piece IOL was used most frequently (61 eyes),
followed by the one-piece design (28 eyes). Posterior
capsule opacification was found in 24 eyes (21.8%). The
Kabi Pharmacia design (3-piece PMMA with a heparin-
Table 2 Prognosis for eyes with total opacified lens.






1 Idiopathic uveitis 0.7 Yes Choroidoretinal patchy
atrophy in macula
2 Idiopathic uveitis 0 None NS
3 Idiopathic uveitis 0.08 None NS
4 Idiopathic uveitis 0.08 None NS
5 Idiopathic uveitis 0.05 None NS
6 Anterior uveitis 0.52 None Cystoid macular edema
7 Anterior uveitis 0.82 None Epiretinal membrane
8 Anterior uveitis 0.05 None NS
9 Intermediate uveitis 0 None NS
10 Intermediate uveitis 0 None NS
11 Behcet’s disease 1.3 None Macular atrophy and
disc pallor
12 VKH 0 None NS
13 Sarcoidosis 0.1 None NS
14 Juvenile arthritis 0 None NS
15 Juvenile arthritis 0.18 None NS
16 Juvenile arthritis 0 None NS
NS Z non-specific; VA Z visual acuity; VKH Z VogteKoyanagieHarada disease.
Cataract surgery outcomes in patients with uveitis 381modified surface) had the highest rate of PCO (7 of 16 eyes;
43.8%), followed by the Alcon AcrySof acrylic three-piece
design (14 of 61 eyes; 23.0%), and the Alcon AcrySof acrylic
one-piece design (3 of 28 eyes; 10.7%); the lowest rate was
observed with the AMO three-piece design (none of five
eyes; 0%) (pZ 0.046). The time points of the PCO diagnosis
according to the IOL design were as follows: the Kabi
Pharmacia was diagnosed at 10.6  7.5 months, the three-
piece AcrySof design was diagnosed at 7.5  6.3 months,
and the one-piece AcrySof design was diagnosed at
5.3  5.9 months. However, the time of PCO onset did not
significantly differ according to the design (p Z 0.42).
Among the eyes with juvenile uveitis, three remained
aphakic, and one eye had an acrylic three-piece IOL
implanted. The best postoperative logMAR VA was 0.03.Table 3 Preoperative and postoperative relapse frequency.
Clinical category Preoperative relapse
frequency (events/y)
mean  SD
VKH (17) 1.25  1.15
Idiopathic uveitis (n Z 15) 1.10  0.98
Behcet’s disease (n Z 11) 1.23  1.07
Anterior uveitis related
to HLA-B27(n Z 10)
2.30  1.63
Panuveitis (n Z 4) 0.68  0.51
Sarcoidosis (n Z 3) 1.00  0.56
Juvenile uveitis (n Z 2) 1.05  1.48
Intermediate uveitis (n Z 0) d
Total (n Z 62) 1.32  1.19
VKH Z VogteKoyanagieHarada disease.The same vision was maintained in three aphakic eyes for 2
years, whereas the pseudophakic eye developed persistent
severe inflammation, band keratopathy, an intractable
pupillary membrane, and peripheral anterior synechiae
with glaucoma formation. The pseudophakic eye had poor
vision 1 year later, and the IOL had to be removed despite
aggressive treatment.Discussion
Early-onset cataracts are common and are a major cause of
visual impairment in various etiologies of uveitis.1,2 The
mean  SD age of these patients was 44.6  18.4 years,





0.80  0.91 0.10
0.35  0.39 0.02
0.27  0.33 0.02
0.33  0.65 0.01
0.38  0.52 d
0.00  0.00 d
1.45  0.64 d
d d
0.48  0.66 <0.001
Table 4 Results of subtenon triamcinolone injection for postoperative cystoid macular edema.
Patient no. Disease category Onset of CME (mo) Poorest VA due
to CME (logMAR)
VA after subtenon TA
injection (logMAR)
1 Idiopathic uveitis 2.00 0.70a 0.70
2 Idiopathic uveitis 4.50 0.52 0.05
3 Idiopathic uveitis 3.50 0.30a 0.30
4 Idiopathic uveitis 3.50 0.40a 0.40
5 Idiopathic uveitis 10.00 0.82 0.16
6 Anterior uveitis 3.50 1.30 0.30
7 Anterior uveitis 1.75 0.30a 0.52
8 Anterior uveitis 1.75 0.15 0.08
9 Panuveitis 4.00 0.40 0.22
10 Behcet’s disease 1.75 0.52 0.08
Mean  SD value 3.6  2.5 0.54  0.33 0.25  0.25
Anterior uveitisZ anterior uveitis related to HLA-B27; CMEZ cystoid macular edema; idiopathic uveitisZ idiopathic anterior uveitis;
logMAR Z logarithm of minimum angle of resolution; TA Z triamcinolone acetate; VA Z visual acuity.
a Structural resolution of CME after triamcinolone subtenon injection.
382 C.-P. Lin et al.However, the predominant etiologies of uveitis in Taiwan
were different from those reported previously. The main
types of cataract-inducing uveitis in Taiwan were idiopathic
anterior uveitis, Behcet’s disease, anterior uveitis related
to HLA-B27, and VKH disease. In a report of patients from
Tubingen, Germany, the mean age was 49.8 years (range
16e86 years) and the predominant types of uveitis were
herpes zoster iridocyclitis and sarcoidosis.11 In a study
conducted in Cleveland, OH, USA, the mean  SD age was
50  13 years and idiopathic uveitis, sarcoidosis, and pars
planitis were the predominant types of uveitis.5 In a study
carried out in Chandigarh, India the mean  SD age was
42.3  13.98 years and presumed tuberculosis, VKH dis-
ease, Behcet’s disease, and sarcoidosis were the most
frequent types of uveitis.12
Although the main clinical etiologies of uveitis in a study
carried out in Miyazaki, Japan (idiopathic uveitis, followed
by Behcet’s disease, VKH disease, and HTLV-1 uveitis) were
similar to those in this Taiwanese study, the mean age in
the Japanese study was 61.7 years (range 30e87 years),8
which is older than the ages reported in the other studies
and in our study. The uveitic cataract is likely to occur in a
young population because chronic inflammation and long-
term corticosteroid use promote cataract develop-
ment.2,13 However, in a report by Kawaguchi et al,8 the
mean age of their patients was significantly older than our
study and other studies.5,11,12 Kawaguchi et al did not
explain why the age of their study group was different from
that of previous reports, but they did not include children
or teenagers in their series.8 Thus it is possible that the
types of uveitis found in children, such as uveitis associated
with juvenile arthritis, were not the major entities in their
study, and the mean age of the subjects was older than in
other studies because they did not include children.
Successful surgery and appropriate perioperative man-
agement might improve vision and result in a better
assessment of the posterior segment.14 Overall, the pa-
tients achieved significant visual improvement in our study,
with 99% of eyes with uveitis gaining three lines or more of
vision after surgery and more than 70% of eyes achieving
20/40 or better vision. Only one eye with preoperative lightperception showed no improvement. Kawaguchi et al and
Harada et al reported visual improvements in 95% and 90%
of eyes, respectively, and the postoperative VA was equal
to or better than 20/40 in 87% and 82% of eyes, respec-
tively.8,15 The patient outcomes obtained in this study do
not appear to be as good as these previous studies. How-
ever, if eyes with pre-existing posterior segment disorders
had been excluded from our series, a postoperative VA
equal to or better than 20/40 would have been attained in
78% of eyes. Behcet’s disease is one of the most common
diseases associated with maculopathy and poor vision.16 In
our series, 22.3% (27/121) of all patients had Behcet’s dis-
ease, which is higher than the figures in the series of
Kawaguchi et al and Harada et al [13.0% (17/131) and 17.9%
(5/28), respectively].8,15 This difference might partly
explain the high rate of maculopathy in our series.
Our logistic regression results showed that the uveitic
etiology (p Z 0.011) and preoperative BCVA (p Z 0.020)
were the significant risk factors associated with a poor
prognosis. Behcet’s disease was an unfavorable predictor
for visual prognosis and patients with Behcet’s disease had
the poorest postoperative vision and the lowest visual
improvement in our study. The recurrent and protracted
course of vasculitis in patients with Behcet’s disease often
leads to irreversible pathological changes in the posterior
pole; this observation has been supported by several
studies.8,11 Although posterior segment involvement with
exudative retinal detachment and subsequent retinal
pigment epithelium changes are often observed in VKH, the
visual outcome of patients with VKH in this study was much
better than that for patients with Behcet’s disease. Recent
optical coherence tomography studies have proposed that
the photoreceptor inner segment/outer segment lines
remain intact in most eyes after acute VKH disease.17 Only
25% of patients with VKH disease have retinal lesions,18
which is much lower than in patients with Behcet’s dis-
ease (93%).16 Most of the cases of poor preoperative VA with
Behcet’s disease or VKH disease resulted from pre-existing
chorioretinopathy or glaucoma-related optic neuropathy,
which may be associated with unfavorable postoperative
vision.14,16,18,19
Cataract surgery outcomes in patients with uveitis 383Predicting visual outcome in the eyes of patients with
uveitis with a completely opacified lens is difficult because
the posterior pole cannot be assessed in detail preopera-
tively. In our study, we found that cataract extraction
resulted in an immediately favorable visual recovery for
these patients, excluding those with macular lesions.14,19
Our results showed that the juvenile uveitis group had a
much better visual outcome than the other etiologies. In all
of these cases, the patients were not susceptible to
amblyopia because the cataract developed after 6 years of
age. Most cases of juvenile uveitis occurred in the anterior
segment, whereas less than 10% were found in the posterior
segment. Therefore a dramatic postoperative visual re-
covery could still be obtained in these patients even if the
cataract progressed to the point of total opacity.20
Posterior synechiae with small pupils are commonly seen
in patients with uveitis during surgery. Our method was to
use synechiolysis by iris hook or iris retractors with small
sphincterotomies. Other mechanical options, including a
cohesive ophthalmic viscosurgical device, Beehler pupil
dilator rings, or pupil dilator rings, have been advocated.21
Surgeons should be aware that excessive manipulation
might result in structural damage (iris tear, iris atonicity,
fixed dilated pupil, and hyphema) or induce severe post-
operative inflammation.21
Postoperative CME developed in 10 of 77 eyes (13.0%)
without evidence of preoperative CME. Our series had a
higher postoperative incidence of CME than those patients
in the study of Kawaguchi et al, who reported a post-
operative CME rate of 6.1%.8 The reason for this may be
twofold. Firstly, some preoperative CMEs might have been
ignored because of either a blurry lens or the lack of a
preoperative optical coherence tomography evaluation of
every patient in our study. Secondly, a major portion of the
disease entities of uveitis in our patients, such as idiopathic
uveitis and anterior uveitis related to HLA-B27, tend to
develop postoperative CME.22
Posterior capsule opacification is a major postoperative
complication in uveitis. The incidence of PCO within 2 years
of surgery was 21.8% in our series, similar to the study of
Kawaguchi et al (23.7%) and to the results in eyes with a
senile cataract.8,23 Many factors can contribute to PCO
formation, such as age,24 haptic and optic design,25 surgical
technique,26 diabetes mellitus,27 and ocular anatomy.26
Kawaguchi et al studied the relationship between PCO
and the material used in IOLs.8 They proposed that the
lowest rate occurred with acrylic IOLs (15%) and then with
PMMA IOLs (44%), whereas the highest rate was associated
with silicone IOLs (50%). Our results showed that the lowest
rate occurred with one-piece acrylic IOLs (10.7%) and the
highest rate occurred with PMMA IOLs with a heparin-
modified surface (43.8%). Both studies had a similar rate
of PCO when using acrylic and PMMA lenses. Although Rauz
et al suggested that the IOL material is not related to PCO
in eyes with uveitis,28 our results and recent studies have
shown a lower rate of PCO with acrylic materials.8,23
The critical issue in obtaining a satisfactory surgical
outcome in patients with uveitis is meticulous perioperative
inflammatory control. Aggressive preoperative steroid
administration is very important in preventing post-
operative complications. Generally, an initial dose of
prednisolone 40 mg/day is given 3 days before surgerycombined with the instillation of topical 1% prednisolone
acetate four times a day for 1 week. After surgery, the
steroid is tapered gradually according to the severity of
inflammation in each patient. In patients with Behcet’s
disease, not only a maintained dose of immunosuppressant,
but also a steroid should be given to reduce the post-
operative complications to their lowest rates.2,11,12,19 Pa-
tients sometimes experience recurrent uveitis
postoperatively, in which instance treatment with immu-
nomodulatory drugs is recommended.29 In this study, we
found that the frequency of relapse was lower after cata-
ract surgery in most groups of patients with uveitis. This
might be due to more aggressive perioperative immuno-
therapy and more frequent postoperative follow-up.
In summary, although phacoemulsification is a chal-
lenging operation in eyes with uveitus because of inflam-
mation and significant structural alterations, such as
posterior synechia, iridocorneal touch, a denser nuclear
sclerosis or POC, and loosened zonules,13,21 it is still
capable of improving visual prognosis in most patients. The
distribution of uveitis is affected by race, genetics, and
geographical variables,30 and the outcomes of patients with
different diseases might be different after surgery. Our
study indicates that the predominant etiologies of uveitis in
Taiwan which cause cataracts are idiopathic uveitis, Beh-
cet’s disease, anterior uveitis related to HLA-B27, and VKH
disease, which are different from those of other
geographical regions; also, the postoperative rate of CME
was higher.7,11 Although the surgical outcome of patients
with uveitic cataract was relatively satisfactory, patients
with Behcet’s disease had the poorest visual recovery in our
study. Although a pre-existing macular lesion would result
in poor visual prognosis,11 the cataract usually obscures the
macular condition and it is difficult to predict the surgical
outcome. The analysis of our results showed that a poor
preoperative VA and Behcet’s disease are two risk factors
related to inadequate visual recovery.References
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